Sign in
4

Changes in Ownership

Werewolf Therapeutics, Inc. Filed Acc 0000899243-23-001404

Options or other derivatives

  • Chief Operating Officer acquired 93,600 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Leonard Reid Chief Operating Officer 2023-01-03 Grant or award · Stock Option (right to buy) +93,600 93,600 D
Loading xslF345X03/doc4.xml…